These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 12692223)

  • 1. Attenuated Salmonella enterica serovar Typhi and Shigella flexneri 2a strains mucosally deliver DNA vaccines encoding measles virus hemagglutinin, inducing specific immune responses and protection in cotton rats.
    Pasetti MF; Barry EM; Losonsky G; Singh M; Medina-Moreno SM; Polo JM; Ulmer J; Robinson H; Sztein MB; Levine MM
    J Virol; 2003 May; 77(9):5209-17. PubMed ID: 12692223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosal DNA vaccine immunization against measles with a highly attenuated Shigella flexneri vector.
    Fennelly GJ; Khan SA; Abadi MA; Wild TF; Bloom BR
    J Immunol; 1999 Feb; 162(3):1603-10. PubMed ID: 9973419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sindbis virus-based measles DNA vaccines protect cotton rats against respiratory measles: relevance of antibodies, mucosal and systemic antibody-secreting cells, memory B cells, and Th1-type cytokines as correlates of immunity.
    Pasetti MF; Ramirez K; Resendiz-Albor A; Ulmer J; Barry EM; Levine MM
    J Virol; 2009 Mar; 83(6):2789-94. PubMed ID: 19129445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonatal immunization with a Sindbis virus-DNA measles vaccine induces adult-like neutralizing antibodies and cell-mediated immunity in the presence of maternal antibodies.
    Capozzo AV; Ramírez K; Polo JM; Ulmer J; Barry EM; Levine MM; Pasetti MF
    J Immunol; 2006 May; 176(9):5671-81. PubMed ID: 16622037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of immune responses induced by intramuscular vaccination with DNA vaccines encoding measles virus hemagglutinin and/or fusion proteins.
    Song MK; Vindurampulle CJ; Capozzo AV; Ulmer J; Polo JM; Pasetti MF; Barry EM; Levine MM
    J Virol; 2005 Aug; 79(15):9854-61. PubMed ID: 16014946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of a More Immunogenic Measles Vaccine by Increasing Its Hemagglutinin Expression.
    Julik E; Reyes-Del Valle J
    J Virol; 2016 Jun; 90(11):5270-5279. PubMed ID: 26984727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful mucosal immunization of cotton rats in the presence of measles virus-specific antibodies depends on degree of attenuation of vaccine vector and virus dose.
    Schlereth B; Buonocore L; Tietz A; Meulen VT; Rose JK; Niewiesk S
    J Gen Virol; 2003 Aug; 84(Pt 8):2145-2151. PubMed ID: 12867646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful vaccine-induced seroconversion by single-dose immunization in the presence of measles virus-specific maternal antibodies.
    Schlereth B; Rose JK; Buonocore L; ter Meulen V; Niewiesk S
    J Virol; 2000 May; 74(10):4652-7. PubMed ID: 10775601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stable Chromosomal Expression of Shigella flexneri 2a and 3a O-Antigens in the Live Salmonella Oral Vaccine Vector Ty21a.
    Dharmasena MN; Osorio M; Takeda K; Stibitz S; Kopecko DJ
    Clin Vaccine Immunol; 2017 Dec; 24(12):. PubMed ID: 29046309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studying experimental measles virus vaccines in the presence of maternal antibodies in the cotton rat model (Sigmodon hispidus).
    Niewiesk S
    Vaccine; 2001 Mar; 19(17-19):2250-3. PubMed ID: 11257342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poor immune responses of newborn rhesus macaques to measles virus DNA vaccines expressing the hemagglutinin and fusion glycoproteins.
    Polack FP; Lydy SL; Lee SH; Rota PA; Bellini WJ; Adams RJ; Robinson HL; Griffin DE
    Clin Vaccine Immunol; 2013 Feb; 20(2):205-10. PubMed ID: 23239799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A chimeric alphavirus replicon particle vaccine expressing the hemagglutinin and fusion proteins protects juvenile and infant rhesus macaques from measles.
    Pan CH; Greer CE; Hauer D; Legg HS; Lee EY; Bergen MJ; Lau B; Adams RJ; Polo JM; Griffin DE
    J Virol; 2010 Apr; 84(8):3798-807. PubMed ID: 20130066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced immunity to Plasmodium falciparum circumsporozoite protein (PfCSP) by using Salmonella enterica serovar Typhi expressing PfCSP and a PfCSP-encoding DNA vaccine in a heterologous prime-boost strategy.
    Chinchilla M; Pasetti MF; Medina-Moreno S; Wang JY; Gomez-Duarte OG; Stout R; Levine MM; Galen JE
    Infect Immun; 2007 Aug; 75(8):3769-79. PubMed ID: 17502396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical safety and biodistribution of Sindbis virus measles DNA vaccines administered as a single dose or followed by live attenuated measles vaccine in a heterologous prime-boost regimen.
    Ramirez K; Barry EM; Ulmer J; Stout R; Szabo J; Manetz S; Levine MM; Pasetti MF
    Hum Gene Ther; 2008 May; 19(5):522-31. PubMed ID: 18507515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosally delivered Salmonella live vector vaccines elicit potent immune responses against a foreign antigen in neonatal mice born to naive and immune mothers.
    Capozzo AV; Cuberos L; Levine MM; Pasetti MF
    Infect Immun; 2004 Aug; 72(8):4637-46. PubMed ID: 15271924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective immunity in macaques vaccinated with a modified vaccinia virus Ankara-based measles virus vaccine in the presence of passively acquired antibodies.
    Stittelaar KJ; Wyatt LS; de Swart RL; Vos HW; Groen J; van Amerongen G; van Binnendijk RS; Rozenblatt S; Moss B; Osterhaus AD
    J Virol; 2000 May; 74(9):4236-43. PubMed ID: 10756037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination with recombinant modified vaccinia virus Ankara protects against measles virus infection in the mouse and cotton rat model.
    Weidinger G; Ohlmann M; Schlereth B; Sutter G; Niewiesk S
    Vaccine; 2001 Apr; 19(20-22):2764-8. PubMed ID: 11282186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA vaccination with both the haemagglutinin and fusion proteins but not the nucleocapsid protein protects against experimental measles virus infection.
    Schlereth B; Germann PG; ter Meulen V; Niewiesk S
    J Gen Virol; 2000 May; 81(Pt 5):1321-5. PubMed ID: 10769075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulated Delayed
    Su H; Liu Q; Wang S; Curtiss R; Kong Q
    Theranostics; 2019; 9(12):3565-3579. PubMed ID: 31281498
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of Vaxfectin adjuvant with DNA vaccine encoding the measles virus hemagglutinin and fusion proteins protects juvenile and infant rhesus macaques against measles virus.
    Pan CH; Jimenez GS; Nair N; Wei Q; Adams RJ; Polack FP; Rolland A; Vilalta A; Griffin DE
    Clin Vaccine Immunol; 2008 Aug; 15(8):1214-21. PubMed ID: 18524884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.